Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.50 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Methylbutanoic Acid SCHEMBL1331498 | 1.00 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL43436 | 1.00 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL9185998 | 0.97 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL6139482 | 0.97 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL8572474 | 0.97 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL6113289 | 0.97 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL8572477 | 0.97 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL15772049 | 0.97 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL8570892 | 0.97 | — | — | |
| 3-Methylbutanoic Acid SCHEMBL8574420 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108779477-B | Method for producing isobutene from 3-methylcrotonyl-CoA | 环球生物能源公司 | 2022-12-13 | — | — | CN | disclosed |
| WO-2022203350-A1 | METHOD AND DIAGNOSIS DEVICE FOR DETERMINING PRESENCE OR ABSENCE OF ATOPY USING MACHINE LEARNING MODEL | 주식회사 에이치이엠파마 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022203351-A1 | METHOD AND DIAGNOSTIC DEVICE FOR DETERMINING PRESENCE OR ABSENCE OF ENTERITIS USING MACHINE LEARNING MODEL | 주식회사 에이치이엠파마 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022203306-A1 | METHOD AND DIAGNOSTIC DEVICE FOR DETERMINING HYPERGLYCEMIA BY USING MACHINE LEARNING MODEL | 주식회사 에이치이엠파마 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022203307-A1 | METHOD FOR DETERMINING WHETHER OBESITY IS PRESENT, BY USING MACHINE LEARNING MODEL, AND DIAGNOSTIC DEVICE | 주식회사 에이치이엠파마 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022203353-A1 | METHOD AND DIAGNOSTIC DEVICE FOR DETERMINING PRESENCE OR ABSENCE OF CONSTIPATION USING MACHINE LEARNING MODEL | 주식회사 에이치이엠파마 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022085941-A1 | METHOD AND APPARATUS FOR DIAGNOSING PRESENCE OR ABSENCE OF COLON POLYPS BY USING MACHINE LEARNING MODEL | 주식회사 에이치이엠파마 | 2022-04-28 | — | — | WO | disclosed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| US-10822628-B2 | Production of thapsigargins by thapsia cell suspension culture | PHYTON HOLDINGS, LLC (US) | 2020-11-03 | — | — | US | disclosed |
| EP-3077523-B1 | PRODUCTION OF THAPSIGARGINS BY THAPSIA CELL SUSPENSION CULTURE | PHYTON HOLDINGS LLC (US) | 2020-05-06 | — | — | EP | disclosed |
| US-20110118363-A1 | Adhesive Composition | EUROMED INC. (US) | 2011-05-19 | — | — | US | disclosed |
| US-20110087038-A1 | PROCESS AND DEVICE FOR THE OXIDATION OF ORGANIC COMPOUNDS | BASF SE (DE) | 2011-04-14 | — | — | US | disclosed |
| WO-2011044449-A1 | ADHESIVE COMPOSITION | EUROMED, INC. (US) | 2011-04-14 | — | — | WO | disclosed |
| EP-2307409-A1 | PYRROLOPYRIDINES AS KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2011-04-13 | — | — | EP | disclosed |
| EP-2300525-A1 | STORAGE-STABLE AQUEOUS EMULSIONS AND LIQUID BLENDS WITH LOW VISCOSITY AS STABILIZERS | BASF SE (DE) | 2011-03-30 | — | — | EP | disclosed |
| US-20110070317-A1 | PYRROLOPYRIDINES AS KINASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2011-03-24 | — | — | US | disclosed |
| US-20110020472-A1 | NON-AQUEOUS GENERATION OF CHLORINE DIOXIDE | DIVERSEY, INC. (US) | 2011-01-27 | — | — | US | disclosed |
| WO-2011002298-A2 | ANIMAL FEED OR HUMAN FOOD FOR IMPROVING INTESTINAL BARRIER PROPERTIES | NUTRECO NEDERLAND B.V. (NL) | 2011-01-06 | — | — | WO | disclosed |
| EP-2269472-A1 | Animal feed for improving intestinal barrier properties | Nutreco Nederland B.V. (NL) | 2011-01-05 | — | — | EP | disclosed |
| US-20090092975-A1 | SELECTABLE MARKER | MOLOGIC LTD (GB) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090092975-A1 | SELECTABLE MARKER | AMD1, PADI1, PSAT1 | TDP1 55/4885ALDH1A1 46/4885CACNA2D1 3960/4885 |
| US-20110020472-A1 | NON-AQUEOUS GENERATION OF CHLORINE DIOXIDE | CLIC1, CLIC4, CAT | TDP1 4421/4885ALDH1A1 1599/4885CACNA2D1 2438/4885 |
| US-20110070317-A1 | PYRROLOPYRIDINES AS KINASE INHIBITORS | CHEK2, CHEK1, BUB1B | TDP1 184/4885ALDH1A1 2477/4885CACNA2D1 3023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.